據以色列廣播公司：以色列官員表示，目前大部分談判集中在霍爾木茲海峽，其他問題的進展尚不清楚。

Middle East specialist Wang Jin says reported US and Israeli plans to strike Iran's energy infrastructure appear aimed at forcing Tehran back to the negotiating table and extracting greater concessions. He warns such strikes would likely escalate tensions. Wang adds he doubts the threats will be carried out; Iran has so far withstood attacks and can retaliate, so sustained US strikes are unlikely to break the current stalemate.

Financial Times: AstraZeneca is exploring a merger with U.S. peer Bristol Myers Squibb that would create one of the world’s largest drugmakers with a combined market value near $400 bln. The companies have held talks in recent months and could reach an agreement soon, but negotiations may also be delayed or collapse. AstraZeneca’s market cap is about £196 bln; Bristol Myers Squibb’s is about $133 bln. The transaction would further accelerate AstraZeneca’s strategic shift toward the U.S. market.